14. April, 2016 at 15:00-17:30 on COBIS, Ole Maaløes Vej 3, 2200 N Copenhagen
DANSK BIOTEK is inviting to a dialogue meeting Thomas Moehler, Vice President, Medical&Scientific Affairs Hematology/Oncology, about evolving strategies in immuno-oncology and cancer vaccines.
"Bioanalytical information about the mutational landscape and activation of signalling cascades of tumor cells has sparked the development of targeted agents. Novel and powerful immuno-therapeutic concepts have recently been developed. These developments have opened new avenues for personalization of therapy for cancer patients. Personalized therapy has the vision and concept to increase the cancer therapy efficacy and decrease the potential adverse events.
Personalized medicine requires specific concepts for clinical development as defining patient eligibility based on biomarkers/molecular markers rather than tumor type, exploring combinatorial therapies and adpative designs.
The interactive seminar is planned to outline the most promising diagnostic tools to guide patient selection. Clinical study designs that are specifically tailored to personalized therapy are presented and discussed. Critical aspects of approach and conduct of clinical studies for immunotherapy in cancer patients will be presented including integration of immune-related response criteria, early response assessments and immunomonitoring in the conduct of clinical studies"
Agenda for presentation:
– Background of immune oncology and targeted agents
– Integration of diagnostic strategies to evaluate cancer mutations and immune status
– Development of personalized therapies with oncology vaccines
– Detection of early signs of efficacy and anti-tumor response in various oncology indications
– Phase I and first-in-man in immuno-oncology and study designs for personalized therapy
– Immune related AE management and immune related response
– Future perspectives
Sign up via this link. no later than 11 April 2016 (or via www.danskbiotek.dk)
The 'Biotech Saloon' committe consists of: Peter Koefoed, Inspicos; Peter Markvardsen ZBM patents; Jan Bjerrum Bach, Jusmedico; Mikkel Vittrup, Plesner; Brian Sørensen, Marselis Advokater; Martin Gantzhorn, Horten; Karin Absalonsen, Nyborg & Rørdam